A WHO communication dated July 10 on the prequalification of the first hepatitis C self-test by WHO is shared.
--------------------
The World Health Organization (WHO) has prequalified the first hepatitis C virus (HCV) self-test which can provide a critical support in expanding access to testing and diagnosis, accelerating global efforts to eliminate hepatitis C.
The product, called OraQuick HCV self-test, manufactured by OraSure Technologies, is an extension of the pre-qualified, OraQuick® HCV Rapid Antibody Test which was initially prequalified by WHO in 2017 for professional use. The self-test version, specifically designed for use by lay users, provides individuals with a single kit containing the components that are needed to perform the self-test.
WHO recommended HCV self-testing (HCVST) in 2021, to complement existing HCV testing services in countries. The recommendation was based on evidence demonstrating its ability to increase access to and uptake of services, particularly among people who may not otherwise test.
National-level HCVST implementation projects, largely supported by Unitaid, have shown high levels of acceptability and feasibility, as well as empowering people through personal choice, autonomy and access to stigma-free self-care services…
See more details in the following link:
https://www.who.int/es/news/item/10-07-2024-who-prequalifies-the-first-s...
------------------------
Jackeline
HIFA-es Moderator
HIFA profile: Jackeline Alger, MD, PhD, is a parasitologist associated to the Department of Clinical Laboratory of the University Hospital; Executive Director of the Antonio Vidal Institute for Infectious Diseases and Parasitology; Tegucigalpa, Honduras. HIFA Country Representative of the Year for the years 2015 and 2018. Email jackelinealger AT gmail.com
Why did I join HIFA? https://www.youtube.com/watch?v=2NZ-U5Wv9FU
Help create a world where people are no longer dying for lack of healthcare knowledge - Join HIFA: www.hifa.org http://www.hifa.org
